Inactive Instrument

Other languages Getinge AB Other OTC

Equities

Getinge Seeks Acquisitions	05-15
En Direct des Marchés : Renault, Eiffage, CGG, Sony, Burberry, Novo Nordisk, Google...	05-15
Getinge limits sale of heart devices in the US after FDA warning	05-15
Borse Europa, STOXX 600 tocca massimi storici su trimestrali e ottimismo taglio tassi	05-10
Europe's STOXX 600 hits record high on earnings, rate cut optimism	05-10
US FDA advises healthcare facilities to switch from Getinge's heart devices	05-08
US FDA recommends healthcare providers switch from Getinge's heart devices	05-08
Soltech Fires Up New Solar Park in Sweden	05-03
GETINGE : Q1 24: Investors look beyond the top-line miss	04-24
Getinge AB Declares A Dividend, Payable on 29 April 2024	04-22
Medical gear maker Getinge's Q1 core profit beats expectations	04-22
Getinge AB Reaffirms Sales Guidance for the Year 2024	04-22
Getinge AB Reports Earnings Results for the First Quarter Ended March 31, 2024	04-22
Getinge’s Covered Stent System Gets EU Medical Device Regulation Certification	04-11
GETINGE : EPS cut (2023: +3.1%, 2024: -10.5%)	04-04
Getinge AB Announces Barbro Fridén Declines Re-Election from the Board	03-15
Getinge AB Proposes Dividend, Payable on April 29, 2024	03-15
Getinge’s Endoscopic Vessel Harvesting System Gets US FDA 510(k) Clearance	03-08
Getinge Takes A Leap Forward in Cardiovascular Surgery with the 510(k) Clearance for Vasoview Hemopro 3	03-08
L'IA, si t'en as pas, t'as raté ta vie (boursière)	03-04

No results for this search

GETINGE : Q1 24: Investors look beyond the top-line miss

April 24, 2024 at 02:06 am